Aspira Women's Health Stock

Aspira Women's Health ROE 2024

Aspira Women's Health ROE

7.06

Ticker

AWH

ISIN

US04537Y1091

WKN

A2P6V3

In 2024, Aspira Women's Health's return on equity (ROE) was 7.06, a -274.02% increase from the -4.06 ROE in the previous year.

Aspira Women's Health Aktienanalyse

What does Aspira Women's Health do?

Aspira Women's Health Inc is a leading company in the field of women's health, specializing in innovative products and services to support women in the detection and treatment of gynecological diseases. Aspira Women's Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Aspira Women's Health's Return on Equity (ROE)

Aspira Women's Health's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Aspira Women's Health's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Aspira Women's Health's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Aspira Women's Health’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Aspira Women's Health stock

What is the ROE (Return on Equity) of Aspira Women's Health this year?

The ROE of Aspira Women's Health this year is 7.06 undefined.

How has the Return on Equity (ROE) of Aspira Women's Health developed compared to the previous year?

The ROE of Aspira Women's Health has increased by -274.02% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Aspira Women's Health?

A high ROE indicates that Aspira Women's Health generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Aspira Women's Health?

A low ROE can indicate that Aspira Women's Health is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Aspira Women's Health affect the company?

A change in ROE (Return on Equity) of Aspira Women's Health can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Aspira Women's Health?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Aspira Women's Health?

Some factors that can influence Aspira Women's Health's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Aspira Women's Health pay?

Over the past 12 months, Aspira Women's Health paid a dividend of 0.52 USD . This corresponds to a dividend yield of about 62.65 %. For the coming 12 months, Aspira Women's Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Aspira Women's Health?

The current dividend yield of Aspira Women's Health is 62.65 %.

When does Aspira Women's Health pay dividends?

Aspira Women's Health pays a quarterly dividend. This is distributed in the months of July, October, April, July.

How secure is the dividend of Aspira Women's Health?

Aspira Women's Health paid dividends every year for the past 0 years.

What is the dividend of Aspira Women's Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aspira Women's Health located?

Aspira Women's Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aspira Women's Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aspira Women's Health from 6/30/2016 amounting to 0.26 USD, you needed to have the stock in your portfolio before the ex-date on 6/17/2016.

When did Aspira Women's Health pay the last dividend?

The last dividend was paid out on 6/30/2016.

What was the dividend of Aspira Women's Health in the year 2023?

In the year 2023, Aspira Women's Health distributed 0 USD as dividends.

In which currency does Aspira Women's Health pay out the dividend?

The dividends of Aspira Women's Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aspira Women's Health

Our stock analysis for Aspira Women's Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aspira Women's Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.